Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.
Arnon TI, Markel G, Bar-Ilan A, Hanna J, Fima E, Benchetrit F, Galili R, Cerwenka A, Benharroch D, Sion-Vardy N, Porgador A, Mandelboim O.
Arnon TI, et al. Among authors: benchetrit f.
PLoS One. 2015 May 4;10(5):e0128052. doi: 10.1371/journal.pone.0128052. eCollection 2015.
PLoS One. 2015.
PMID: 25938552
Free PMC article.
No abstract available.